市場調査レポート

商品コード

1633545

マイクロエレクトロニクス医療用インプラントの市場規模、シェア、成長分析：製品タイプ別、技術別、用途別、エンドユーザー別、地域別 - 産業予測、2025年～2032年

Microelectronic Medical Implants Market Size, Share, Growth Analysis, By Product Type, By Technology (Radiofrequency Technology, Bluetooth Low Energy ), By Application, By End-User, By Region - Industry Forecast 2025-2032

出版日: 2025年01月12日
発行: SkyQuest
ページ情報: 英文 210 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 3,500 504,210円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 4,400 633,864円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 5,300 763,518円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
目次

概要

サンプル依頼リストに入れる

マイクロエレクトロニクス医療用インプラントの世界市場規模は2023年に323億5,000万米ドルと評価され、2024年の344億9,000万米ドルから2032年には575億米ドルに成長し、予測期間（2025-2032年）のCAGRは6.6％で成長する見通しです。

世界のマイクロエレクトロニクス医療用インプラント市場は堅調な成長軌道にあり、より小型で効果的なインプラントを生み出すマイクロエレクトロニクスとナノテクノロジーの技術進歩がその原動力となっています。この技術革新は、世界の慢性疾患の蔓延と高齢化に対処しながら、患者の予後を向上させる。心血管障害や神経障害、聴覚障害などの疾患が、これらのインプラントの需要を牽引しており、ウェアラブルデバイスと統合してリアルタイムのモニタリングも可能です。しかし、研究開発費の高騰、サイバーセキュリティへの懸念、FDAやEMAなどの規制当局による厳しい承認プロセスなどの課題も残っています。さらなる成長を実現するためには、業界各社はコスト抑制戦略に投資し、データセキュリティ対策を強化し、複雑な規制環境を効率的に乗り切る必要があります。

市場概要
ペースメーカーと除細動器
- 植込み型除細動器（ICD）
- 心臓再同期療法装置（CRT）
神経刺激装置
- 脳深部刺激装置
- 脊髄刺激装置
- 仙骨神経刺激装置
埋め込み型薬剤ポンプ
- 脊髄内ドラッグデリバリーシステム
- インスリンポンプ
人工内耳
- 片側人工内耳
- 両側人工内耳
脊椎固定刺激装置
- 内部刺激装置
- 外部刺激装置

マイクロエレクトロニクス医療用インプラント市場規模：技術別& CAGR（2025-2032）

市場概要
無線周波数（RF）技術
Bluetooth低エネルギー（BLE）
Zigbee
近距離無線通信（NFC）
その他

マイクロエレクトロニクス医療用インプラント市場規模：用途別& CAGR（2025-2032）

市場概要
心臓病学
- 不整脈管理
- 心不全の管理
神経学
- パーキンソン病
- てんかん
- 慢性疼痛管理
眼科
- 網膜疾患
- 緑内障
整形外科
- 骨成長刺激
- 脊椎固定術

マイクロエレクトロニクス医療用インプラント市場規模：エンドユーザー別& CAGR（2025-2032）

市場概要
病院
クリニック
外来手術センター
ホームケア設定

マイクロエレクトロニクス医療用インプラント市場規模：地域別& CAGR（2025-2032）

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の前年比比較（2022-2024）

主要企業プロファイル

Medtronic（Ireland）
Johnson & Johnson MedTech（United States）
Abbott Laboratories（United States）
Siemens Healthineers（Germany）
Stryker Corporation（United States）
Philips Healthcare（Netherlands）
GE HealthCare（United States）
Becton, Dickinson and Company（BD）（United States）
Boston Scientific Corporation（United States）
Zimmer Biomet Holdings, Inc.（United States）
Cochlear Limited（Australia）
LivaNova PLC（United Kingdom）
Biotronik（Germany）
Schiller AG（Switzerland）
Koninklijke Philips N.V.（Netherlands）
Abiomed, Inc.（United States）
Sonova Holding AG（Switzerland）
NeuroPace, Inc.（United States）
Johnson & Johnson Vision（United States）

結論と推奨事項

Product Code: SQMIG35A2689

Global Microelectronic Medical Implants Market size was valued at USD 32.35 billion in 2023 and is poised to grow from USD 34.49 billion in 2024 to USD 57.5 billion by 2032, growing at a CAGR of 6.6% during the forecast period (2025-2032).

The global microelectronic medical implants market is on a robust growth trajectory, fueled by technological advancements in microelectronics and nanotechnology that produce smaller, more effective implants. This innovation enhances patient outcomes while addressing the increasing prevalence of chronic diseases and an aging population worldwide. Conditions such as cardiovascular and neurological disorders, along with hearing impairments, are driving demand for these implants, which also integrate with wearable devices for real-time monitoring. However, challenges persist, including high R&D costs, cybersecurity concerns, and stringent regulatory approval processes from bodies like the FDA and EMA. To unlock further growth, industry players must invest in cost containment strategies, enhance data security measures, and efficiently navigate complex regulatory environments.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microelectronic Medical Implants market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Microelectronic Medical Implants Market Segmental Analysis

Global Microelectronic Medical Implants Market is segmented by Product Type, Technology, Application, End-User and region. Based on Product Type, the market is segmented into Pacemakers & Defibrillators, Neurostimulators, Implantable Drug Pumps, Cochlear Implants and Spinal Fusion Stimulators. Based on Technology, the market is segmented into Radiofrequency (RF) Technology, Bluetooth Low Energy (BLE), Zigbee, Near Field Communication (NFC) and Others. Based on Application, the market is segmented into Cardiology, Neurology, Ophthalmology and Orthopedics. Based on End-User, the market is segmented into Hospitals, Clinics, Ambulatory Surgical Centers and Home Care Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Microelectronic Medical Implants Market

The global microelectronic medical implants market is significantly driven by ongoing innovations in microelectronics technology. These advancements have facilitated the miniaturization of medical implants, resulting in more compact and efficient devices. As a result, the performance of microelectronic medical implants has markedly improved, providing enhanced treatment options and better patient outcomes. This evolution not only optimizes medical interventions but also expands the potential applications of such implants in various healthcare scenarios. Consequently, the synergy between technology and healthcare continues to spur growth in the microelectronic medical implants market, meeting the increasing demand for advanced medical solutions.

Restraints in the Global Microelectronic Medical Implants Market

The global microelectronic medical implants market faces several restraints, notably the high costs associated with implantable devices. The extensive research, development, and manufacturing processes contribute to substantial expenses, resulting in elevated prices for these innovative products. Such financial barriers can restrict access to advanced medical technologies, especially in areas with constrained healthcare budgets or among patients lacking sufficient insurance coverage. This situation hinders the adoption of microelectronic medical implants, potentially limiting their availability to those who could greatly benefit from these groundbreaking medical advancements. Ultimately, the high cost presents a significant challenge for both healthcare providers and patients alike.

Market Trends of the Global Microelectronic Medical Implants Market

The Global Microelectronic Medical Implants market is witnessing a significant trend towards the diversification of neurostimulation devices, which are increasingly being employed to address a broader spectrum of medical conditions. Beyond their traditional role in chronic pain management, these innovative implants are now being utilized to treat epilepsy, Parkinson's disease, depression, and obesity, reflecting an expanding interest in their therapeutic potential. This shift is driven by advancements in technology, improved patient outcomes, and growing acceptance of these devices within clinical settings. As research continues to unveil new applications, the market is poised for robust growth and innovation in neurostimulation therapies.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Technology Advancement
Regulatory Landscape
Patent Analysis

Global Microelectronic Medical Implants Market Size by Product Type & CAGR (2025-2032)

Market Overview
Pacemakers & Defibrillators
- Implantable Cardioverter Defibrillators (ICDs)
- Cardiac Resynchronization Therapy Devices (CRT)
Neurostimulators
- Deep Brain Stimulators
- Spinal Cord Stimulators
- Sacral Nerve Stimulators
Implantable Drug Pumps
- Intrathecal Drug Delivery Systems
- Insulin Pumps
Cochlear Implants
- Unilateral Cochlear Implants
- Bilateral Cochlear Implants
Spinal Fusion Stimulators
- Internal Stimulators
- External Stimulators

Global Microelectronic Medical Implants Market Size by Technology & CAGR (2025-2032)

Market Overview
Radiofrequency (RF) Technology
Bluetooth Low Energy (BLE)
Zigbee
Near Field Communication (NFC)
Others

Global Microelectronic Medical Implants Market Size by Application & CAGR (2025-2032)

Market Overview
Cardiology
- Arrhythmia Management
- Heart Failure Management
Neurology
- Parkinson's Disease
- Epilepsy
- Chronic Pain Management
Ophthalmology
- Retinal Disorders
- Glaucoma
Orthopedics
- Bone Growth Stimulation
- Spinal Fusion

Global Microelectronic Medical Implants Market Size by End-User & CAGR (2025-2032)

Market Overview
Hospitals
Clinics
Ambulatory Surgical Centers
Home Care Settings

Global Microelectronic Medical Implants Market Size & CAGR (2025-2032)

North America (Product Type, Technology, Application, End-User)
- US
- Canada
Europe (Product Type, Technology, Application, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Technology, Application, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Technology, Application, End-User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Technology, Application, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson MedTech (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Philips Healthcare (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE HealthCare (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD) (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zimmer Biomet Holdings, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cochlear Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova PLC (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biotronik (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Schiller AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Koninklijke Philips N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abiomed, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sonova Holding AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NeuroPace, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson Vision (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments